News Sigrid Therapeutics launches Glucose Stabiliser in the US, an over-the-counter dietary supplement designed to control blood sugar and body weight By Sana | News | No Comments
News Sigrid Therapeutics Secures $4 Million in Oversubscribed Funding Round to Tap Into Booming Obesity and Diabetes Market By Sana | News | No Comments
News Sigrid Therapeutics announces appointment of distinguished Professor Iain Chapple to Scientific Advisory Board By Sana | News | No Comments
News Sigrid Therapeutics rapporterar positiva resultat från konsumenttest av SiPore®, en produkt avsedd för prediabetiker, typ 2-diabetiker och överviktiga för kontroll av blodsockernivån By Sana | News | No Comments
News Sigrid Therapeutics reports positive results from consumer blood sugar management trial using SiPore® formulated dietary supplements in pre-diabetics, type 2 diabetics, and obese individuals By Sana | News | No Comments
News Sigrid Therapeutics tar in ytterligare 10,6 miljoner kronor i övertecknad företrädesemission för att påskynda kommersialiseringen av SiPore® By Sana | News | No Comments
News Sigrid Therapeutics raises further SEK10.6 million in oversubscribed rights issue for accelerated SiPore® commercialization By Sana | News | No Comments
News Sigrid Therapeutics utser Mattias Ankerberg, en internationell ledarprofil från konsumentvarubranschen till ordförande By Sana | News | No Comments
News Sigrid Therapeutics appoints internationally established consumer industry executive Mattias Ankarberg as Chairman By Sana | News | No Comments
